Literature DB >> 23945301

[The prevalence and risk factors of bronchiectasis in residents aged 40 years old and above in seven cities in China].

Yu-min Zhou1, Chen Wang, Wan-zhen Yao, Ping Chen, Jian Kang, Shao-guang Huang, Bao-yuan Chen, Chang-zheng Wang, Dian-tao Ni, Sheng-ming Liu, Xiao-ping Wang, Da-li Wang, Jia-chun Lü, Jin-ping Zheng, Nan-shan Zhong, Pi-xin Ran.   

Abstract

OBJECTIVE: To investigate the prevalence and risk factors of bronchiectasis in urban city of China.
METHODS: A cross-sectional survey was conducted in 17 urban areas in Beijing, Shanghai, Tianjin, Chongqing cities, and Guangdong, Liaoning, Shanxi provinces. In this study, urban population-based cluster samples were randomly selected from each city/province. In the selected city communities, all residents at least 40 years old were recruited, interviewed with questionnaires and tested with spirometry. Each participant was asked whether he/she was ever diagnosed as bronchiectasis by physician, whether had symptoms of respiratory diseases and possible risk factors, etc. RESULT: Data of 10 811 participants was enrolled for analysis, with a response rate of 75.4% (10 811/14 337). The overall prevalence of physician-diagnosed bronchiectasis was 1.2% (135/10 811), with 1.5% (65/4382) in male and 1.1% (70/6429) in female, without statistical difference in gender (χ² = 3.289, P = 0.070). Prevalence of bronchiectasis increased with age (χ² = 31.029, P < 0.001). There were no statistical significances in crude prevalences of bronchiectasis among cities (χ² = 10.572, P = 0.103), while there was a significant difference among cities after adjustment with confounders (Wald value = 22.116, P = 0.001), by using logistic regression analysis. Logistic regression analysis showed, bronchiectasis was significantly associated with elder ( ≥ 70 years vs 40-49 years; OR = 4.11, 95% CI 2.29-7.36), the family history of respiratory diseases (having two subjects with respiratory diseases in family vs no suffered relatives; OR = 2.04, 95% CI 1.06-3.94), respiratory infection during childhood (suffering two kinds of respiratory diseases vs never; OR = 4.89, 95% CI 2.03-11.81), exposure to coal (OR = 2.30, 95% CI 1.17-4.52), chronic pharyngitis (OR = 3.96, 95% CI 1.38-11.40) and pulmonary tuberculosis (OR = 3.07, 95% CI 1.89-4.98), heart diseases (OR = 1.64, 95% CI 1.11-2.42) and lung cancer(OR = 18.61, 95% CI 7.67-45.18).
CONCLUSION: The prevalence of bronchiectasis in population aged 40 years old and above in urban area in China is high and associated with multiple factors such as age, family history of respiratory diseases, respiratory infection during childhood, exposure to coal, chronic pharyngitis, pulmonary tuberculosis, heart diseases, lung cancer and so on.

Entities:  

Mesh:

Year:  2013        PMID: 23945301

Source DB:  PubMed          Journal:  Zhonghua Nei Ke Za Zhi        ISSN: 0578-1426


  14 in total

1.  Impact of different etiologies of bronchiectasis on the pulmonary function tests.

Authors:  Agnaldo José Lopes; Gustavo Bittencourt Camilo; Sara Lucia Silveira de Menezes; Fernando Silva Guimarães
Journal:  Clin Med Res       Date:  2014-11-07

Review 2.  The clinical phenotype of bronchiectasis and its clinical guiding implications.

Authors:  Li Gao; Ke-Ru Qin; Ting Li; Hai-Long Wang; Min Pang
Journal:  Exp Biol Med (Maywood)       Date:  2020-11-26

Review 3.  Efficiency and safety of surgical intervention to patients with Non-Cystic Fibrosis bronchiectasis: a meta-analysis.

Authors:  Li-Chao Fan; Shuo Liang; Hai-Wen Lu; Ke Fei; Jin-Fu Xu
Journal:  Sci Rep       Date:  2015-12-02       Impact factor: 4.379

Review 4.  A Systematic Review of the Prevalence and Pattern of Imaging Defined Post-TB Lung Disease.

Authors:  Jamilah Meghji; Hope Simpson; S Bertel Squire; Kevin Mortimer
Journal:  PLoS One       Date:  2016-08-12       Impact factor: 3.240

5.  Clinical features related to hospital expenses for non-cystic fibrosis bronchiectasis in China.

Authors:  Yanliang Ma; Daishun Liu; Yingqun Ji; Xuemei Wei; Dianzhu Pan; Fei Xu; Qingguo Di; Xiaoju Chen; Fengming Luo; Jiujin Zhang; Guiying Ou; Yan Zhang; Kaishu Li; Dong Zhang; Wanping Wang; Jinfu Xu; Jianying Li; Dan Zhu; Feng Tian; Manqi Fan
Journal:  J Int Med Res       Date:  2020-06       Impact factor: 1.671

Review 6.  Tuberculosis and lung damage: from epidemiology to pathophysiology.

Authors:  Shruthi Ravimohan; Hardy Kornfeld; Drew Weissman; Gregory P Bisson
Journal:  Eur Respir Rev       Date:  2018-02-28

7.  Respiratory symptoms and health-related quality of life in post-tuberculosis subjects with physician-diagnosed bronchiectasis: a cross-sectional study.

Authors:  Taehee Kim; Hyun Lee; Yun Su Sim; Bumhee Yang; Hye Yun Park; Seung Won Ra; Hyo Jun Jang; Seung-Jin Yoo; Sang-Heon Kim; Jang Won Sohn; Ho Joo Yoon; Yeon-Mok Oh; Yong-Soo Kwon; Hayoung Choi
Journal:  J Thorac Dis       Date:  2021-08       Impact factor: 2.895

8.  Factors associated with bronchiectasis in patients with moderate-severe chronic obstructive pulmonary disease.

Authors:  Jianmin Jin; Wenling Yu; Shuling Li; Lijin Lu; Xiaofang Liu; Yongchang Sun
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

9.  Investigation into the Individualized Treatment of Traditional Chinese Medicine through a Series of N-of-1 Trials.

Authors:  Haiyin Huang; Peilan Yang; Jie Wang; Yingen Wu; Suna Zi; Jie Tang; Zhenwei Wang; Ying Ma; Yuqing Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2018-02-07       Impact factor: 2.629

10.  Bronchiectasis Management in China, What We Can Learn from European Respiratory Society Guidelines.

Authors:  Ning Wang; Jie-Ming Qu; Jin-Fu Xu
Journal:  Chin Med J (Engl)       Date:  2018-08-20       Impact factor: 2.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.